Rupee at 80: Neutral impact for India's pharma industry, say experts | Business Standard News

2022-07-23 01:00:25 By : Mr. Jerome Lin

Topics Rupee vs dollar | Rupee | US Dollar

https://mybs.in/2ax7fBN

The rupee has dropped nearly 7 per cent vis-à-vis the US dollar (USD) year-to-date in calendar year 2022 to the psychological mark of 80. However, the impact of this rupee depreciation is likely to be largely neutral for the Indian pharmaceutical sector, say industry insiders, as the benefits may be offset by rising input costs.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

Please wait while you are being redirected to the next page.

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

Copyrights © 2022 Business Standard Private Ltd. All rights reserved.